Published in J Clin Pathol on October 01, 1986
Proceedings: The faecal flora of patients with Crohn's disease. Antonie Van Leeuwenhoek (1975) 2.52
Elemental diets in treatment of acute Crohn's disease. Br Med J (1980) 1.92
Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology (1984) 1.79
The faecal flora of patients with Crohn's disease. J Hyg (Lond) (1981) 1.46
An international study of agglutinins to Eubacterium, Peptostreptococcus and Coprococcus species in Crohn's disease, ulcerative colitis and control subjects. Digestion (1983) 1.14
Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) (1982) 4.08
An oral preparation to release drugs in the human colon. Br J Clin Pharmacol (1982) 3.49
Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br J Cancer (1978) 3.38
Incidence of Crohn's disease in Cardiff between 1934-1977. Gut (1979) 3.35
Transdermal nicotine for active ulcerative colitis. N Engl J Med (1994) 2.90
Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86
Myelopoiesis in the zebrafish, Danio rerio. Blood (2001) 2.67
Natural history of patients with x-ray-negative dyspepsia in general practice. Br Med J (1972) 2.67
Breakfast and dietary aspects of Crohn's disease. Br Med J (1978) 2.57
Tumour-necrosis factor from the rabbit. II. Production by monocytes. Br J Cancer (1978) 2.48
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21
Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro. J Immunol (1975) 2.07
Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut (1988) 2.05
Epidemiological aspects of Crohn's disease: a review of the literature. Gut (1984) 2.04
Smoking habits in psoriasis: a case control study. Br J Dermatol (1992) 2.03
Osteoporosis in patients with inflammatory bowel disease. Gut (1987) 1.95
Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J (1980) 1.88
Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis. Br J Clin Pharmacol (1983) 1.80
Production of an anti-tumour cytotoxin by human monocytes. Immunology (1981) 1.78
Altered bowel habit and menstruation. Lancet (1976) 1.73
Transoesophageal echocardiography during scoliosis repair: comparison with CVP monitoring. Can J Anaesth (1998) 1.71
Transcriptional regulation of beta-defensin gene expression in tracheal epithelial cells. Infect Immun (2000) 1.69
Monitoring of sympathetic tone to assess postoperative pain: skin conductance vs surgical stress index. Anaesthesia (2009) 1.67
Mortality in Crohn's disease. Q J Med (1980) 1.62
Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion (1987) 1.60
Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59
Treating irritable bowel syndrome with peppermint oil. Br Med J (1979) 1.57
pH of the contents of the duodenal bulb in relation to duodenal ulcer. Gut (1966) 1.57
[Not Available]. BioDrugs (1997) 1.56
Controlled trial of azathioprine in Crohn's disease. Lancet (1971) 1.56
Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis. Aliment Pharmacol Ther (2000) 1.55
Complications of carbenoxolone therapy. Br Med J (1974) 1.54
Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system. Br J Cancer (1976) 1.53
The effect of healing on bile reflux in gastric ulcer. Gut (1971) 1.51
Tumour-necrosis factor from the rabbit. IV. Purification and chemical characterization. Br J Cancer (1980) 1.47
Altered expression of human monocyte Fc receptors in malignant disease. Nature (1977) 1.46
Treatment of ulcerative colitis with oral 5-aminosalicyclic acid in patients unable to take sulphasalazine. Lancet (1983) 1.44
Increased sugar consumption in Crohn's disease. Digestion (1980) 1.42
Schiff base forming drugs: mechanisms of immune potentiation and therapeutic potential. J Mol Med (Berl) (1996) 1.41
Information assessment by patients of a booklet on Crohn's disease. Public Health (1985) 1.41
Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg (1991) 1.40
Petit mal status: an unusual cause of confusion. Br J Hosp Med (1990) 1.40
Allescheria boydii infections in the immunosuppressed host. Am J Med (1977) 1.40
Diagnosis of oesophageal spasm by ergometrine provocation. Gut (1982) 1.40
Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer. Gut (1966) 1.40
Genomic deletion marking an emerging subclone of Francisella tularensis subsp. holarctica in France and the Iberian Peninsula. Appl Environ Microbiol (2007) 1.39
Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet (1983) 1.37
Etiology of gastric ulcer. Gastroenterology (1972) 1.37
Bile damage to the gastric mucosal barrier: the influence of pH and bile acid concentration. Gastroenterology (1971) 1.36
Achalasia in the city of Cardiff from 1926 to 1977. Digestion (1980) 1.36
'Esophageal angina' as the cause of chest pain. JAMA (1982) 1.33
Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet (1999) 1.31
Incidence of ulcerative colitis in the Cardiff region 1968-1977. Gut (1984) 1.29
Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J Interv Card Electrophysiol (2000) 1.29
Has the rising incidence of Crohn's disease reached a plateau? Br Med J (Clin Res Ed) (1982) 1.29
Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut (1985) 1.29
Production of an anti-tumour cytotoxin by human monocytes: comparison of endotoxin, interferons and other agents as inducers. Br J Cancer (1982) 1.28
Measurement of atrial septal defect size: a comparative study between three-dimensional transesophageal echocardiography and the standard balloon sizing methods. Pediatr Cardiol (2000) 1.28
Screening protocol for Torulopsis (Candida) glabrata. J Clin Microbiol (1996) 1.27
Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut (1992) 1.26
Tumour-necrosis factor from the rabbit. III. Relationship to interferons. Br J Cancer (1979) 1.23
Incidence of Crohn's disease in Cardiff over 60 years: 1986-1990 an update. Eur J Gastroenterol Hepatol (1995) 1.23
Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology (1993) 1.22
5-aminosalicylic acid in serum and urine after administration by enema to patients with colitis. J Pharm Pharmacol (1983) 1.22
Maintenance of remission in ulcerative colitis with 5-amino salicylic acid in high doses by mouth. Br Med J (Clin Res Ed) (1983) 1.21
Role of smoking in inflammatory bowel disease: implications for therapy. Postgrad Med J (2000) 1.20
Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis. Br J Clin Pharmacol (1984) 1.19
Agglutinins to bacteria in Crohn's disease. Gut (1980) 1.19
Coarse mucosal folds in the duodenum. Q J Med (1968) 1.18
Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol (1992) 1.17
Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut (1993) 1.17
Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. Immunology (1988) 1.17
Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids. Eur J Immunol (1986) 1.17
Mortality in acute upper gastrointestinal haemorrhage: a six-year survey from the University Hospital of Wales. Postgrad Med J (1981) 1.15
Neutral amino acid uptake by the microvillous plasma membrane of the human placenta is inversely related to fetal size at birth in normal pregnancy. J Clin Endocrinol Metab (1998) 1.15
Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. Br J Cancer (1981) 1.13
Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci (1981) 1.13
Effect of ulcerative colitis and smoking on rectal blood flow. Gut (1990) 1.13
Fungal endophthalmitis following intraocular lens implantation. Am J Ophthalmol (1977) 1.12
Inherited thrombocytopenia, elevated serum IgA and renal disease: identification as a variant of the Wiskott-Aldrich syndrome. Q J Med (1986) 1.12
A controlled trial of glycopyrronium and l-hyoscyamine in the long-term treatment of duodenal ulcer. Gut (1970) 1.12
Evaluation of a diagnostic algorithm for heart disease in neonates. BMJ (1991) 1.11
Immunoglobulin E in rectal mucosa of patients with proctitis. Lancet (1975) 1.11
Diurnal variation in the quantitative EEG in healthy adult volunteers. Br J Clin Pharmacol (2000) 1.11
Increased reflux of bile into the stomach in gastric ulcer. Gut (1968) 1.10
Receptor for monomeric IgM on guinea-pig splenic macrophages. Nature (1973) 1.10
Inhibition of gastric acid secretion with a mast cell stabiliser, FPL-52694. Br J Clin Pharmacol (1981) 1.10
Angina-like esophageal pain: differentiation from cardiac pain by history. J Clin Gastroenterol (1985) 1.07
A homeodomain protein selectively expressed in noradrenergic tissue regulates transcription of neurotransmitter biosynthetic genes. J Neurosci (1995) 1.07
Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin. Immunology (1983) 1.07
Analysis of inhibition of lymphocyte cytotoxicity in human colon carcinoma. Br J Cancer (1975) 1.07
Effect of information booklet on patients' anxiety levels and consultation rates in Crohn's disease. Public Health (1986) 1.05
Bile reflux in gastro-oesophageal disease. Clin Gastroenterol (1977) 1.05
Immunogenicity of lipid-conjugated antigens. II. Anti-complementary activity and antigen trapping in the spleen. Immunology (1980) 1.04